AKEBIA THERAPEUTICS, INC. (AKBA) Operating income 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) annual operating income history from SEC filings — each fiscal year as reported.
$23.5MFY2025 · since FY2016: -$136.5M → $23.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $23.5M | +146.6% |
| FY2024 | -$50.5M | -9.1% |
| FY2023 | -$46.3M | +42.7% |
| FY2022 | -$80.8M | +69.5% |
| FY2021 | -$264.5M | +30.0% |
| FY2020 | -$377.8M | -32.0% |
| FY2019 | -$286.3M | -60.7% |
| FY2018 | -$178.2M | -132.4% |
| FY2017 | -$76.7M | +43.8% |
| FY2016 | -$136.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AKBA financial trends
AKBA RevenueAKBA Net incomeAKBA Net marginAKBA Gross profitAKBA Gross marginAKBA Operating marginAKBA Operating cash flowAKBA Free cash flowAKBA Capital expendituresAKBA Return on equityAKBA Stock buybacksAKBA Dividends paidAKBA Total assetsAKBA Total liabilitiesAKBA Shareholders’ equityAKBA overview →